ARCHIVES

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

This article is from The Cancer Letter archive.

Vol. 28 No. 16 | April 19, 2002

Download PDF Visit The Full Archive

Related Articles

Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week

September 23, 1994

Hammer Agrees To Bush Request for FDA Probe

July 15, 1988

House panel gives NIH 0.5 percent increase, matching the President’s budget request.

June 17, 2005

ASCO: NCI Authorities Still Important

June 11, 2010

In Brief: Centers Awarded Gifts; Georgetown Launches $40m Campaign; Herberman Named To PA Board

February 1, 1991

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012